À¶Ý®ÊÓƵ

Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
À¶Ý®ÊÓƵ

TREATMENT OF HEPATIC-FAILURE SECONDARY TO ISONIAZID HEPATITIS WITH LIVER-TRANSPLANTATION

À¶Ý®ÊÓƵ

TREATMENT OF HEPATIC-FAILURE SECONDARY TO ISONIAZID HEPATITIS WITH LIVER-TRANSPLANTATION DIGESTIVE DISEASES AND SCIENCES Farrell, F. J., Keeffe, E. B., Man, K. M., Imperial, J. C., Esquivel, C. O. 1994; 39 (10): 2255-2259

Abstract

Two patients with liver failure secondary to isoniazid hepatotoxicity were successfully treated with orthotopic liver transplantation. A 49-year-old man received isoniazid prophylaxis for a positive tuberculin test, and a 60-year-old woman was treated for active pulmonary tuberculosis with isoniazid, rifampin, and pyrazinamide. Both patients developed hepatic failure 4 and 1.5 months after initiation of antituberculous drug therapy, respectively. Liver transplantation was performed for progressive hepatic failure and was successful in both patients. The patient with active pulmonary tuberculosis was successfully treated with a modified antituberculous drug regimen while taking standard doses of immunosuppressive drugs after transplantation. In conclusion, liver transplantation is feasible and effective therapy for patients with isoniazid-induced hepatic failure, and active pulmonary tuberculosis may represent a relative rather than absolute contraindication to transplantation.

View details for

View details for